CD44 and breast cancer: Finally, we selected 245 cases CD44+CD24− (breast cancer stem cells phenotype marker) breast cancer patients from TCGA dataset to analyze correlation of EPAS1 with Wnt and Notch pathways related factors, and c-Myc.